USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking Sells 5,198 Shares

USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking sold 5,198 shares of the stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total value of $232,662.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

USANA Health Sciences Stock Up 0.3 %

Shares of USNA traded up $0.12 during midday trading on Tuesday, hitting $44.74. The company’s stock had a trading volume of 61,789 shares, compared to its average volume of 81,501. The stock has a market capitalization of $858.91 million, a price-to-earnings ratio of 13.94, a price-to-earnings-growth ratio of 1.38 and a beta of 0.94. The company’s fifty day simple moving average is $46.54 and its two-hundred day simple moving average is $48.15. USANA Health Sciences, Inc. has a one year low of $41.45 and a one year high of $69.60.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.35. The firm had revenue of $221.08 million during the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. On average, research analysts predict that USANA Health Sciences, Inc. will post 2.75 earnings per share for the current year.

Institutional Trading of USANA Health Sciences

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in USANA Health Sciences by 2.5% in the third quarter. Vanguard Group Inc. now owns 1,567,182 shares of the company’s stock valued at $91,853,000 after purchasing an additional 38,533 shares in the last quarter. Pzena Investment Management LLC boosted its position in shares of USANA Health Sciences by 3.1% during the first quarter. Pzena Investment Management LLC now owns 785,344 shares of the company’s stock valued at $38,089,000 after purchasing an additional 23,729 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in USANA Health Sciences by 3.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 677,664 shares of the company’s stock worth $36,323,000 after purchasing an additional 21,524 shares during the period. Pacer Advisors Inc. increased its stake in shares of USANA Health Sciences by 75.7% during the fourth quarter. Pacer Advisors Inc. now owns 337,371 shares of the company’s stock valued at $18,083,000 after purchasing an additional 145,373 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in USANA Health Sciences by 4.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 222,423 shares of the company’s stock worth $11,922,000 after acquiring an additional 8,536 shares in the last quarter. 54.25% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on USNA. DA Davidson reduced their price objective on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a research report on Tuesday. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Friday, January 12th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.